|
Name |
Isocoumarin
|
Molecular Formula | C9H6O2 | |
IUPAC Name* |
isochromen-1-one
|
|
SMILES |
C1=CC=C2C(=C1)C=COC2=O
|
|
InChI |
InChI=1S/C9H6O2/c10-9-8-4-2-1-3-7(8)5-6-11-9/h1-6H
|
|
InChIKey |
IQZZFVDIZRWADY-UHFFFAOYSA-N
|
|
Synonyms |
Isocoumarin; 1H-2-Benzopyran-1-one; 491-31-6; 1H-isochromen-1-one; isochromen-1-one; 3,4-Benzo-2-pyrone; CHEBI:38759; SR89982S3E; Isocoumarins; UNII-SR89982S3E; SCHEMBL76183; CHEMBL457811; DTXSID8060080; ZINC1846628; MFCD08061387; AKOS006285714; AS-76786; FT-0607868; N10038; EN300-6487432; Q412756; Benzoic acid, 2-(2-hydroxyethenyl)-, delta-lactone; Z1198175817
|
|
CAS | 491-31-6 | |
PubChem CID | 68108 | |
ChEMBL ID | CHEMBL457811 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 146.14 | ALogp: | 1.9 |
HBD: | 0 | HBA: | 2 |
Rotatable Bonds: | 0 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 26.3 | Aromatic Rings: | 2 |
Heavy Atoms: | 11 | QED Weighted: | 0.571 |
Caco-2 Permeability: | -4.402 | MDCK Permeability: | 0.00003110 |
Pgp-inhibitor: | 0.001 | Pgp-substrate: | 0.439 |
Human Intestinal Absorption (HIA): | 0.005 | 20% Bioavailability (F20%): | 0.343 |
30% Bioavailability (F30%): | 0.845 |
Blood-Brain-Barrier Penetration (BBB): | 0.216 | Plasma Protein Binding (PPB): | 89.66% |
Volume Distribution (VD): | 0.628 | Fu: | 12.10% |
CYP1A2-inhibitor: | 0.973 | CYP1A2-substrate: | 0.62 |
CYP2C19-inhibitor: | 0.761 | CYP2C19-substrate: | 0.192 |
CYP2C9-inhibitor: | 0.269 | CYP2C9-substrate: | 0.56 |
CYP2D6-inhibitor: | 0.038 | CYP2D6-substrate: | 0.677 |
CYP3A4-inhibitor: | 0.021 | CYP3A4-substrate: | 0.208 |
Clearance (CL): | 4.801 | Half-life (T1/2): | 0.576 |
hERG Blockers: | 0.164 | Human Hepatotoxicity (H-HT): | 0.081 |
Drug-inuced Liver Injury (DILI): | 0.852 | AMES Toxicity: | 0.182 |
Rat Oral Acute Toxicity: | 0.775 | Maximum Recommended Daily Dose: | 0.027 |
Skin Sensitization: | 0.232 | Carcinogencity: | 0.822 |
Eye Corrosion: | 0.627 | Eye Irritation: | 0.992 |
Respiratory Toxicity: | 0.683 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000167 | 0.488 | D0K1XK | 0.367 | ||||
ENC000025 | 0.488 | D0O6IZ | 0.356 | ||||
ENC005617 | 0.431 | D0B1FE | 0.339 | ||||
ENC000041 | 0.405 | D02WCI | 0.333 | ||||
ENC002806 | 0.404 | D0D5GG | 0.327 | ||||
ENC000169 | 0.391 | D04JEE | 0.323 | ||||
ENC003033 | 0.389 | D08SKH | 0.322 | ||||
ENC000047 | 0.378 | D09ZIS | 0.315 | ||||
ENC000892 | 0.372 | D0QV5T | 0.314 | ||||
ENC000678 | 0.368 | D03GET | 0.308 |